Satsuma Pharmaceuticals, Inc. Operating Cash Flow
Satsuma Pharmaceuticals, Inc. reported Operating Cash Flow of -$11.38 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-05-11
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$11.38M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$12.09M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$13.42M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$11.69M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$51.52M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$43.00M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$42.33M.
- Satsuma Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$29.64M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$11.38M 10-Q · filed 2023-05-11 | -$23.48M derived: sum of 2 quarters · filed 2023-05-11 | -$36.90M derived: sum of 3 quarters · filed 2023-05-11 | -$48.58M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | -$12.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$25.51M derived: sum of 2 quarters · filed 2023-03-28 | -$37.20M derived: sum of 3 quarters · filed 2023-03-28 | -$51.52M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$13.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$25.11M derived: sum of 2 quarters · filed 2022-11-03 | -$39.42M 10-Q · filed 2022-11-03 | -$53.02M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-06-30 | -$11.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$26.00M 10-Q · filed 2022-08-09 | -$39.60M derived: sum of 3 quarters · filed 2023-05-11 | -$49.42M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | -$14.32M 10-Q · filed 2023-05-11 | -$27.92M derived: sum of 2 quarters · filed 2023-05-11 | -$37.73M derived: sum of 3 quarters · filed 2023-05-11 | -$48.83M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$13.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$23.41M derived: sum of 2 quarters · filed 2023-03-28 | -$34.51M derived: sum of 3 quarters · filed 2023-03-28 | -$43.00M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$9.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$20.91M derived: sum of 2 quarters · filed 2022-11-03 | -$29.39M 10-Q · filed 2022-11-03 | -$38.00M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$11.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$19.58M 10-Q · filed 2022-08-09 | -$28.18M derived: sum of 3 quarters · filed 2022-08-09 | -$38.90M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$8.48M 10-Q · filed 2022-05-10 | -$17.09M derived: sum of 2 quarters · filed 2022-05-10 | -$27.80M derived: sum of 3 quarters · filed 2022-05-10 | -$37.80M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$19.32M derived: sum of 2 quarters · filed 2022-03-15 | -$29.31M derived: sum of 3 quarters · filed 2022-03-15 | -$42.33M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$10.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$20.71M derived: sum of 2 quarters · filed 2021-11-09 | -$33.73M 10-Q · filed 2021-11-09 | -$40.91M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$9.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$23.01M 10-Q · filed 2021-08-10 | -$30.20M derived: sum of 3 quarters · filed 2021-08-10 | -$41.52M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$13.02M 10-Q · filed 2021-05-11 | -$20.20M derived: sum of 2 quarters · filed 2021-05-11 | -$31.52M derived: sum of 3 quarters · filed 2021-05-11 | -$39.59M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$18.50M derived: sum of 2 quarters · filed 2021-03-25 | -$26.58M derived: sum of 3 quarters · filed 2021-03-25 | -$29.64M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$11.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$19.39M derived: sum of 2 quarters · filed 2020-11-10 | -$22.45M 10-Q · filed 2020-11-10 | -$24.17M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$8.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$11.13M 10-Q · filed 2020-08-11 | -$12.86M derived: sum of 3 quarters · filed 2020-08-11 | |
| 2019-03-31 | -$3.06M 10-Q · filed 2020-05-12 | -$4.78M derived: sum of 2 quarters · filed 2020-05-12 | ||
| 2018-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$6.98M 10-K · filed 2020-03-10 | ||
| 2018-09-30 | -$5.26M 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | -$4.32M 10-K · filed 2020-03-10 |